Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 16, 2016. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2015. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 26.5B USD
- Positions
- 64
- Share of the ten largest
- 52.0%
The ten largest positions Q4 2015
- Broadcom 7.4%▲ +43.2%
- Allergan PLC 7.0%▼ −17.0%
- Amazon 6.5%▼ −14.9%
- Teva Pharmaceutical Inds Ltd 6.2%▲ +182.3%
- Alphabet Inc. (Class A) 5.4%new
- Pioneer Nat Res Co 4.4%▲ +40.6%
- Walgreens Boots Alliance Inc 4.1%▼ −45.1%
- Avago Technologies Ltd 4.0%▲ +6.1%
- Elevance Health 3.5%▲ +13.1%
- Netflix 3.4%▲ +73.6%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2015
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AVGO Broadcom | 7.4% | 33,747,218 | 2.0B USD | +43.2% increased | Q3 2015 2 quarters |
| Allergan PLC | 7.0% | 5,978,075 | 1.9B USD | −17.0% reduced | Q2 2015 3 quarters |
| AMZN Amazon | 6.5% | 2,567,446 | 1.7B USD | −14.9% reduced | Q2 2015 3 quarters |
| Teva Pharmaceutical Inds Ltd | 6.2% | 25,043,775 | 1.6B USD | +182.3% increased | Q3 2015 2 quarters |
| GOOGL Alphabet Inc. (Class A) | 5.4% | 1,853,460 | 1.4B USD | new | Q4 2015 1 quarter |
| Pioneer Nat Res Co | 4.4% | 9,371,105 | 1.2B USD | +40.6% increased | Q1 2014 8 quarters |
| Walgreens Boots Alliance Inc | 4.1% | 12,771,497 | 1.1B USD | −45.1% reduced | Q4 2014 5 quarters |
| Avago Technologies Ltd | 4.0% | 7,364,891 | 1.1B USD | +6.1% increased | Q2 2015 3 quarters |
| ELV Elevance Health | 3.5% | 6,686,965 | 932.4M USD | +13.1% increased | Q2 2015 3 quarters |
| NFLX Netflix | 3.4% | 7,842,269 | 897.0M USD | +73.6% increased | Q3 2015 2 quarters |
| GOOG Alphabet Inc. (Class C) | 3.3% | 1,146,435 | 870.0M USD | new | Q4 2015 1 quarter |
| LYB LyondellBasell | 3.1% | 9,328,028 | 810.6M USD | −30.9% reduced | Q2 2013 or earlier 11 quarters |
| Valeant Pharmaceuticals Intl | 3.0% | 7,793,397 | 792.2M USD | +56.1% increased | Q2 2013 or earlier 11 quarters |
| HUM Humana | 2.9% | 4,331,936 | 773.3M USD | +12.4% increased | Q3 2014 6 quarters |
| APD Air Products | 2.6% | 5,385,451 | 700.7M USD | −9.0% reduced | Q3 2014 6 quarters |
| Cheniere Energy Inc | 2.2% | 15,920,523 | 593.0M USD | +21.9% increased | Q3 2014 6 quarters |
| MCK McKesson Corporation | 2.1% | 2,761,995 | 544.7M USD | +21.4% increased | Q2 2015 3 quarters |
| Canadian Pac Ry Ltd | 1.9% | 4,001,587 | 510.6M USD | −3.8% reduced | Q4 2013 9 quarters |
| Priceline Grp Inc | 1.9% | 393,214 | 501.3M USD | new | Q4 2015 1 quarter |
| Qunar Cayman Is Ltd | 1.7% | 8,522,747 | 449.5M USD | +78.3% increased | Q4 2014 5 quarters |
| Laboratory Corp Amer HLDGS | 1.5% | 3,208,708 | 396.7M USD | −36.5% reduced | Q3 2015 2 quarters |
| TDG TransDigm Group | 1.4% | 1,600,128 | 365.5M USD | +40.5% increased | Q2 2015 3 quarters |
| BNY BNY Mellon | 1.4% | 8,805,531 | 363.0M USD | −14.4% reduced | Q3 2014 6 quarters |
| CMG Chipotle Mexican Grill | 1.2% | 689,383 | 330.8M USD | new | Q4 2015 1 quarter |
| NKE Nike, Inc. | 1.2% | 5,262,662 | 328.9M USD | +48.7% increasedafter 2:1 stock split | Q3 2015 2 quarters |
| Endo Intl PLC | 1.0% | 4,520,954 | 276.8M USD | new | Q4 2015 1 quarter |
| CCI Crown Castle | 1.0% | 2,995,866 | 259.0M USD | −33.4% reduced | Q4 2014 5 quarters |
| TXT Textron | 0.9% | 5,817,245 | 244.4M USD | +56.6% increased | Q3 2015 2 quarters |
| PFE Pfizer | 0.9% | 7,424,690 | 239.7M USD | new | Q4 2015 1 quarter |
| Cabot Oil & Gas Corp | 0.9% | 13,410,258 | 237.2M USD | new | Q4 2015 1 quarter |
| HAL Halliburton | 0.9% | 6,667,076 | 226.9M USD | new | Q4 2015 1 quarter |
| Anadarko Pete Corp | 0.8% | 4,590,975 | 223.0M USD | new | Q4 2015 1 quarter |
| C Citigroup | 0.8% | 4,271,971 | 221.1M USD | −4.4% reduced | Q3 2014 6 quarters |
| Envision Healthcare HLDGS In | 0.8% | 7,808,316 | 202.8M USD | −20.8% reduced | Q1 2015 4 quarters |
| VRTX Vertex Pharmaceuticals | 0.7% | 1,421,673 | 178.9M USD | +5.7% increased | Q4 2014 5 quarters |
| Ctrip Com Intl Ltd | 0.7% | 3,767,142 | 174.5M USD | −23.3% reduced | Q4 2014 5 quarters |
| KHC Kraft Heinz | 0.6% | 2,082,693 | 151.5M USD | new | Q4 2015 1 quarter |
| Kite Pharma Inc | 0.5% | 2,207,203 | 136.0M USD | −10.7% reduced | Q2 2015 3 quarters |
| Aetna Inc New | 0.5% | 1,247,101 | 134.8M USD | −64.2% reduced | Q2 2015 3 quarters |
| BABA Alibaba Group (ADR) | 0.5% | 1,629,041 | 132.4M USD | −34.4% reduced | Q3 2014 6 quarters |
| 58 Com Inc | 0.5% | 1,867,746 | 123.2M USD | +8.7% increased | Q3 2015 2 quarters |
| BIIB Biogen | 0.4% | 368,864 | 113.0M USD | new | Q4 2015 1 quarter |
| PRU Prudential Financial | 0.4% | 1,213,808 | 98.8M USD | new | Q4 2015 1 quarter |
| Ace Ltd | 0.4% | 831,759 | 97.2M USD | −27.1% reduced | Q3 2015 2 quarters |
| Legg Mason Inc | 0.4% | 2,469,033 | 96.9M USD | 0.0% reduced | Q4 2014 5 quarters |
| MRSH Marsh McLennan | 0.3% | 1,592,022 | 88.3M USD | new | Q4 2015 1 quarter |
| Monsanto Co New | 0.3% | 895,800 | 88.3M USD | new | Q4 2015 1 quarter |
| Southwestern Energy Co | 0.3% | 11,673,609 | 83.0M USD | new | Q4 2015 1 quarter |
| Calpine Corp | 0.3% | 4,881,477 | 70.6M USD | new | Q4 2015 1 quarter |
| Akorn Inc | 0.3% | 1,841,346 | 68.7M USD | new | Q4 2015 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 64 positions.
Breakdown by sector
- Communication Services 12.1%
- Health Care 10.5%
- Consumer Discretionary 9.0%
- Technology 7.4%
- Materials 5.7%
- Financials 3.2%
- Industrials 2.4%
- Real Estate 1.0%
- Energy 0.9%
- Consumer Staples 0.6%
- not in our coverage 47.3%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors